BUPARVAX contains Buparvaquone, a second-generation hydroxynaphthoquinone used for the treatment and prophylaxis of theileriosis in cattle. It acts directly on the mitochondrial electron transport system of Theileria parasites, inhibiting their respiratory processes.

Buparvax is active against both the schizont and piroplasm stages of Theileria spp. It may be used during the incubation period of the disease or after clinical signs have developed.

Pack Size: 20 ml and 50 ml Vials

Benefits

• Effective for the treatment and prophylaxis of theileriosis.
• Active against Theileria parva and Theileria annulata.
• Provides activity against both schizont and piroplasm stages of Theileria spp.
• Can be used during the incubation period of the disease.
• Can also be used when clinical signs are apparent.
• Acts directly on the parasite’s mitochondrial electron transport and respiratory system.
• Indicated for important forms of tick-transmitted theileriosis in cattle.

Indications

For the treatment of tick-transmitted theileriosis in cattle caused by intracellular protozoan parasites:

• Theileria parva — associated with East Coast fever, Corridor disease and Zimbabwean theileriosis.
• Theileria annulata — associated with tropical theileriosis.

Contraindications / Precautions

Due to the inhibitory effects of theileriosis on the immune system, vaccination should be delayed until the animal has recovered from theileriosis.

Withdrawal Period

• Meat: 42 days
• Milk: 2 days

Storage Conditions

Store below 30°C in a dry place away from direct sunlight.

Keep out of reach of children.

Note: The supplied information does not specify dosage, route of administration or Buparvaquone concentration, so I have not added them.